News
Stay ahead with up‑to‑date medical news from around the world, plus the latest trial data and guideline updates summarized by our scientific team. You’ll also find concise overviews of specific therapy areas in our clinical insights articles, with key takeaways you can apply to your practice today.
Sign up to our newsletter for updates straight to your inbox.
Latest news
Nivolumab: No DFS benefit in NSCLC
Phase 3 EA5142 results presented at ASCO 2026
No OS detriment with durvalumab
POTOMAC shows stable OS and QoL
Ivonescimab improves OS in NSCLC
HARMONi-6 shows OS benefit vs PD-1
MFS benefit with apalutamide
PROTEUS shows improved MFS outcomes
ASCO 2026: TALAPRO-3 results
Data from ASCO 2026 show talazoparib improved rPFS
QoL stable with EV+pembro
EYNOTE-905 shows QoL stability